Nice close, helped along by a little promotion in the Australian today. NXM finally starting to get some spotlight
Nexus Minerals
Nexus Minerals (NXM) is another junior plotting a run into production via a known gold deposit.
The 28,000 ounce high-grade Pinnacles deposit is too small for owner Saracen (SAR) to bother with, but it looks set to underpin a brighter future Nexus.
Nexus is earning an 85 per cent interest in Pinnacles from Saracen and is about to start a new drilling program to follow more high-grade hits reported in December to hopefully increase the size of the resource.
Nexus would like to see Pinnacles grow towards the 100,000 ounce mark to underpin a 25,000-ounce-a-year operation that could theoretically throw off as much as $15m in annual free cashflow. The key to that potential being realised is the ore sale and purchase with Saracen. It is not a tolling agreement but would involve Nexus delivering broken ore to Saracen’s Carosue Dam treatment plant 13km to the north in return for a gold-price-linked deduction.
Nexus has its eyes out for similar opportunities in the WA goldfields and would ideally like to take a cookie-cutter approach and secure four or five similar deals, the key again being access to someone else’s treatment plant.
It is an interesting strategy made all the more interesting by Nexus’ modest market cap: $6.7m, or slightly more than its cash position of $5.8m at yesterday’s 9.5c a share. Cash remains king for the juniors, as is a tight capital base, as they transition into producers. After 10 years of the boards, it only has 70 million shares on issue.
http://www.theaustralian.com.au/bus...g/news-story/e49d8b6b032b699ba60f210cfacb2360
- Forums
- ASX - By Stock
- Those gold grades are amazing and better at depth
NXM
nexus minerals limited
Add to My Watchlist
0.00%
!
7.1¢

Nice close, helped along by a little promotion in the Australian...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.86M |
Open | High | Low | Value | Volume |
7.0¢ | 7.5¢ | 7.0¢ | $23.85K | 328.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 29931 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 109633 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29931 | 0.070 |
1 | 40000 | 0.067 |
1 | 195000 | 0.066 |
3 | 330800 | 0.065 |
1 | 450000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 109633 | 1 |
0.074 | 17500 | 1 |
0.080 | 70000 | 2 |
0.084 | 20386 | 2 |
0.085 | 18418 | 2 |
Last trade - 15.55pm 27/06/2025 (20 minute delay) ? |
Featured News
NXM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online